|
WO2019217822A1
|
|
Compounds and methods of using compounds for the prevention or treatment of inflammatory conditions
|
|
WO2019200369A1
|
|
Compounds and methods of using compounds for the prevention or treatment of peripheral nerve damage
|
|
WO2019140253A1
|
|
Compounds, compositions, and methods for modulating salty taste
|
|
BR112020011344A2
|
|
tryptophan derivatives as sweeteners
|
|
EP3484310A2
|
|
Compounds, compositions, and methods for modulating sweet taste
|
|
WO2017189778A1
|
|
Methods, compounds, and compositions, for modulating sweet taste
|
|
WO2017156432A1
|
|
Steviol glycoside esters
|
|
CN107428714A
|
|
For adjusting compound, composition and the method for sweet taste
|
|
AU2016206784A1
|
|
Compounds, compositions, and methods for modulating sweet taste
|
|
AU2015258252A1
|
|
Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste
|
|
US2017304306A1
|
|
SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES
|
|
US2017303574A1
|
|
Compounds, compositions, and methods for modulating sweet taste
|
|
US2017188606A1
|
|
Compounds, compositions, and methods for reducing or eliminating bitter taste
|
|
JP2015097539A
|
|
SELECTION AND ISOLATION OF LIVING CELLS BY mRNA-BINDING PROBE
|
|
AU2014318979A1
|
|
Sodium channel modulators for the treatment of pain and diabetes
|
|
WO2014176336A1
|
|
Assays for identifying compounds that modulate bitter taste
|
|
CA2900852A1
|
|
Methods and materials using signaling probes
|
|
WO2014153000A1
|
|
Compounds, compositions, and methods for modulating sweet taste
|
|
AU2014234105A1
|
|
Sodium channel modulators for the treatment of pain
|
|
US2013323726A1
|
|
Methods and materials using signaling probes
|
